Neuren Pharmaceuticals | NEU - Cash And Equivalent


Neuren Pharmaceuticals reported AUD5.91M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Genetic Signatures AUD 7.47M 33.32M Jun/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Organon & Co USD 672M 73M Sep/2025
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Telix Pharmaceuticals AUD 207.16M 503.19M Jun/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025